-
Paula Burton joins the SCIAD team as Project Director
I am delighted to have joined SCIAD Communications as Project Director, working with the team to support the continued success of life science and healthcare businesses. Whilst face-to-face networking might be ‘on hold’ for the time being, I am very much looking forward to meeting clients virtually, and in person, in the not-too-distant future. I have…
-
Solentim to supply cell line development solutions for Samsung Biologics’ new R&D center in San Francisco
Bournemouth, UK, 7th October 2020 / Sciad Newswire / Solentim is pleased to announce the adoption of its VIPS™ single cell seeding platform and Cell Metric® CLD into Samsung Biologics’ new research and development facility in San Francisco, CA. These instruments are designed for single cell cloning and assurance of monoclonality to increase the speed and efficiency of Master Cell Bank development. Samsung’s…
-
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering
NanoSyrinx is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and protein delivery system identified in an undisclosed organism. The company will focus on direct cytosolic delivery of genome editing enzymes and therapeutic proteins in vivo, with key applications in the cell and gene therapy space. Coventry, UK, 30th September 2020 / Sciad Newswire…
-
Navigating the challenges of mass vaccine production
New opinion piece from Watson-Marlow Fluid Technology Group launched today. Falmouth, UK, 28th September 2020 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) launches a new article discussing the challenges of rapidly scaling up vaccine production to meet global demands. The opinion piece looks at the significant progress being made in the development of novel vaccine candidates for…
-
Solentim launches new workflow for single cell cloning of stem cells
VIPS™ + MatriClone™ combination ensures high efficiency seeding of hiPSCs with high viability. Bournemouth, UK, 23rd September 2020 / Sciad Newswire / Solentim, the global leader for solutions to create, isolate and characterize the highest value cells for the development of new biological medicines, yesterday launched a dedicated new workflow for single cell cloning of human induced pluripotent stem cells (hiPSCs). A combination of Solentim’s VIPS™ (verified…
-
Examen reports a surge in demand for sperm DNA fragmentation tests following Covid-19 pause on services
Eileen Regan joins Examen as Chief Commercial Officer as the company expands to meet the needs of the UK’s top fertility clinics Belfast, Northern Ireland, 21st September 2020 / Sciad Newswire / Examen, a world leader in male fertility testing, announces the expansion of its senior management team, with the appointment of Eileen Regan who joins as Chief Commercial…
-
Huntington Study Group Announces a Partnership with Prilenia Therapeutics to Conduct a Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease
Rochester, NY, USA, 17th September 2020 / Sciad Newswire / The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R. Hayden, MD, PhD, to conduct PRidopidine Outcome On Function in Huntington’s Disease (PROOF-HD) clinical study. PROOF-HD is a global…
-
Is stainless steel the bioprocessing technology of the past?
Falmouth, UK, 17th September 2020 / Sciad Newswire / Single-use technology has been touted as the latest and most promising development in bioprocessing technology, fast replacing stainless steel as the material of choice for many bioprocessing engineers. Marc Pelletier, Director of CRB, and Mark Embury from ASEPCO, part of Watson Marlow Fluid Technology Group (WMFTG) which has…
-
WEP Clinical joins with Wren Healthcare to provide home healthcare services
London, UK, 14th September 2020 / Sciad Newswire / WEP Group Holdings Limited (WEP), a specialist CRO focused on delivering lifesaving drugs to patients that have an unmet clinical need, is expanding its capabilities by making a strategic investment in Wren Healthcare Limited (Wren), a successful and growing clinical nursing healthcare provider in the EU. Wren works with…
-
Check4Cancer launches online service to provide fast cancer screening as thousands of people go untested in the Covid-19 pandemic
Cambridge, UK, 14th September 2020 / Sciad Newswire / Check4Cancer, the provider of early cancer detection and genetic services, has launched its new brand and website bringing together all of its cancer services onto one platform. The new integrated service makes it even easier to access rapid, affordable cancer screening and diagnostic tests for people concerned about…